how do the glp 1 shots work GLP-1 and Anesthesia: Considerations and Cautions for CRNAs The Latest on GLP-1s |

Flexible Dose Range

According to the STEP 1 trial published in the New England Journal of Medicine, patients taking semaglutide 2.4 mg (Wegovy) achieved approximately: 3% to 5% body weight loss by week 12 10% to 12% body weight loss by week 28 15% to 17% body weight loss by week 68 (maximum effect) These figures represent average outcomes in clinical trials

Weight Loss Injections in NYC Unlock your weight loss potential with GLP-1 therapy

This genetic information can support a more informed discussion with your provider about whether compounded semaglutide, tirzepatide, or a dual-compound protocol (GLP-Squared) aligns best with your physiology and treatment goals, ensuring both affordability and clinical appropriateness

TrimRx had Wegovy in their published menu

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial